Skip to main content
Normal View

Medicinal Products Availability

Dáil Éireann Debate, Thursday - 5 March 2020

Thursday, 5 March 2020

Questions (885)

Bernard Durkan

Question:

885. Deputy Bernard J. Durkan asked the Minister for Health if provision has been made by the HSE to expand the availability of anti-IL-5 therapies for severe asthma in 2020; the number of patients that were able to access same in 2019; the number expected to be able to access same in 2020; and if he will make a statement on the matter. [3806/20]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share